Prevention of ovarian hyperstimulation syndrome in a rat model: efficacy comparison between cabergoline and meloxicam

Abstract Objective. To compare the efficacy of cabergoline (Cb2) and meloxicam in curbing vascular endothelial growth factor (VEGF) expression and preventing ovarian hyperstimulation syndrome (OHSS). Design. Randomized controlled, animal study. Setting. Academic facility. Sample. We used a total of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta obstetricia et gynecologica Scandinavica 2010-05, Vol.89 (5), p.692-699
Hauptverfasser:	Saylan, Arif, Arioz, Dagistan Tolga, Koken, Tulay, Dilek, Husniye, Saylan, Filiz, Yilmazer, Mehmet
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis of Variance Animal model Animals Biological and medical sciences Biopsy, Needle Body Weight Bones, joints and connective tissue. Antiinflammatory agents cabergoline Chorionic Gonadotropin - pharmacology Disease Models, Animal Dose-Response Relationship, Drug Drug Administration Schedule Ergolines - pharmacology Female Gynecology. Andrology. Obstetrics Immunohistochemistry Injections, Intramuscular Medical sciences meloxicam OHSS Organ Size Ovarian Hyperstimulation Syndrome - pathology Ovarian Hyperstimulation Syndrome - prevention & control Ovary - drug effects Ovary - pathology Ovulation Induction - adverse effects Ovulation Induction - methods Pharmacology. Drug treatments Pregnancy Pregnancy, Animal Probability Random Allocation Rats Rats, Wistar Thiazines - pharmacology Thiazoles - pharmacology Vascular Endothelial Growth Factor A - analysis VEGF
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!